PubRank

Bela Merkely

Author PubWeight™ 56.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012 10.38
2 Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006 5.39
3 Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med 2012 4.49
4 Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med 2014 3.80
5 Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2009 2.68
6 The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol 2013 1.79
7 A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J 2015 1.68
8 Dyssynchrony and the risk of ventricular arrhythmias. JACC Cardiovasc Imaging 2013 1.56
9 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm 2012 1.54
10 Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2013 1.53
11 Clinical impact, safety, and efficacy of single- versus dual-coil ICD leads in MADIT-CRT. J Cardiovasc Electrophysiol 2013 1.52
12 Stabilization of the coronary sinus electrode position with coronary stent implantation to prevent and treat dislocation. J Cardiovasc Electrophysiol 2007 1.49
13 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 2012 1.46
14 Cardiac magnetic resonance imaging in children with chronic kidney disease and renal transplantation. Pediatr Transplant 2012 1.44
15 Gold-tip electrodes--a new "deep lesion" technology for catheter ablation? In vitro comparison of a gold alloy versus platinum-iridium tip electrode ablation catheter. J Cardiovasc Electrophysiol 2005 1.41
16 Clinical significance of ventricular tachyarrhythmias in patients treated with CRT-D. Heart Rhythm 2013 1.40
17 Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. J Cardiovasc Electrophysiol 2004 1.18
18 Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty). JACC Cardiovasc Interv 2011 1.13
19 Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts. BMJ 2012 1.06
20 Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction. Am Heart J 2013 0.94
21 Images in cardiovascular medicine. Cardiac contusion in a professional soccer player: visualization of acute and late pathological changes in the myocardium with magnetic resonance imaging. Circulation 2010 0.87
22 Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countries--data from the European Heart Rhythm Association White Book. Europace 2011 0.84
23 Electrical atrial fibrillation induction affects the characteristics of induced arrhythmia. J Electrocardiol 2007 0.83
24 Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Heart Rhythm 2013 0.80
25 Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial. Circulation 2013 0.80
26 Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart J 2012 0.79
27 A new endocardial "over-the-wire" or stylet-driven left ventricular lead: first clinical experience. Pacing Clin Electrophysiol 2005 0.79
28 Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world. Int J Cardiol 2010 0.78
29 The effect of ICD programming on inappropriate and appropriate ICD Therapies in ischemic and nonischemic cardiomyopathy: the MADIT-RIT trial. J Cardiovasc Electrophysiol 2015 0.78
30 Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience. Eur J Heart Fail 2014 0.78
31 Barriers to implementation of evidence-based electrical therapies and the need for outcome research: role of European registries. Europace 2011 0.78
32 Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT. Heart Rhythm 2012 0.77
33 The coexistence of dynamin 2 mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy. Clin Neuropathol 2015 0.77
34 Coronary vasoconstrictor effect of ghrelin is not mediated by growth hormone secretagogue receptor 1a type in dogs. Peptides 2010 0.77
35 Life after coronary stent thrombosis. Med Sci Monit 2009 0.77
36 Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study. Arch Cardiovasc Dis 2010 0.76
37 Assessment of heart rate recovery after exercise stress test: implications for cardiac resynchronization therapy. Europace 2011 0.75
38 Non-reentrant atrioventricular nodal tachycardia. Clin Res Cardiol 2013 0.75
39 High-volume lesions using a new second-generation open irrigation radiofrequency catheter are associated with the development of inhomogeneous lesions. Pacing Clin Electrophysiol 2014 0.75
40 Successful emergency ablation of ventricular tachycardia in the early postoperative period after left ventricular assist device implantation. Clin Res Cardiol 2015 0.75
41 Exploring in-hospital death from myocardial infarction in Eastern Europe: from the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC); on the Behalf of the Working Group on Coronary Pathophysiology & Microcirculation of the European Society of Cardiology. Curr Vasc Pharmacol 2014 0.75
42 Radiofrequency ablation at low irrigation flow rates using a novel 12-hole gold open-irrigation catheter. Pacing Clin Electrophysiol 2013 0.75
43 Direct comparison of steroid and non-steroid eluting small surface pacing leads: randomized, multicenter clinical trial. Cardiol J 2013 0.75
44 Long-term clinical follow-up after drug-eluting stent implantation for bare metal in-stent restenosis. J Interv Cardiol 2013 0.75
45 Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis. Hellenic J Cardiol 2014 0.75
46 Dual-chamber pacemaker implantation via both superior vena cavae in a patient with persistent left superior vena cava. Heart Rhythm 2010 0.75
47 Single-step atrial thrombus exclusion and internal cardioversion of atrial fibrillation via a transesophageal echocardiography probe. J Am Coll Cardiol 2005 0.75